Get past bacterial resistance with ocular antibiotic armamentarium

Article

Continued evolution in the landscape of bacterial resistance and antimicrobial agents is mandating careful prescribing of anti-infective medications to optimize success in prophylactic and therapeutic indications and to minimize future problems associated with pathogen resistance.

"The first successful clinical use of an antibiotic was 80 years ago and was for an ocular infection. We've come a long way since then in developing new antibiotics with new mechanisms of action, but we have also managed to use these agents in ways where many no longer work," noted Dr. May, who is in private practice in northern Mississippi and serves as adjunct faculty for Southern College of Optometry, Memphis, TN.

Dr. May explained that subtherapeutic and long-term dosing are both culprits in promoting bacterial resistance so that it is important to not taper antibiotic treatment regimens and use only a short-term course when prescribing an anti-infective agent as surgical prophylaxis.

Antimicrobial choices

Currently, fluoroquinolones are the most widely used anti-infective agents for ocular infections. However, older peptide antibiotics, bacitracin and polymixin B, and folic acid synthesis inhibitors, such as sulfacetamide and trimethoprim, can be a useful and cost-effective option in appropriately selected situations.

Proper prescribing depends on understanding the spectrum of activity of the various agents and whether they are bacteriostatic or bactericidal.

The folic acid synthesis inhibitors are bacteriostatic agents that have good activity against gram-positive bacteria. However, these agents should not be used in anyone with known sulfonamide sensitivity or in the management of more serious infections because they are bacteriostatic agents.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.